Results 161 to 170 of about 41,694 (206)

The utility of multi-b-value diffusion and arterial spin labelling magnetic resonance imaging in gliomas grading and prediction of isocitrate dehydrogenase status. [PDF]

Quant Imaging Med Surg
Kopřivová T, Dostál M, Jůza T, Vybíhal V, Neuman E, Ovesná P, Kozubek M, Keřkovský M.   +7 more
europepmc   +1 more source

Differential isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 mutation-related landscape in intrahepatic cholangiocarcinoma. [PDF]

Oncologist
Xu S, Cao L, Chen R, Ye C, Li Q, Jiang Q, Yan F, Wan M, Zhang X, Ruan J.   +9 more
europepmc   +1 more source

Metal coordination and enzymatic reaction of the glioma-target R132H isocitrate dehydrogenase 1: Insights by molecular simulations. [PDF]

PLoS One
Raghavan B, De Vivo M, Carloni P.
europepmc   +1 more source

Magnetic resonance imaging fractal analysis of O(6)-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase wild-type glioblastoma. [PDF]

Quant Imaging Med Surg
Xue C, Wang K, Dong W, Han T, Zhou Q, Zhang P, Liang L, Wang P, Zhou J, Guan S, Liu X.   +10 more
europepmc   +1 more source

Isocitrate dehydrogenase of soybeans.

Indian journal of biochemistry & biophysics, 1975
R C, Gupta, R, Narayan
openaire   +1 more source

Survival Impact of Isocitrate Dehydrogenase (IDH)-Wildtype Histological Versus Molecular Glioblastoma: A Propensity Score-Matched Analysis. [PDF]

Cureus
Patil N, Dube S, Mutua F, Kakumanu S, Shankar JJ, Sinha N, Pareek V.   +6 more
europepmc   +1 more source

The value of multi-parametric magnetic resonance imaging (MRI) radiomics in predicting isocitrate dehydrogenase (IDH) wildtype with telomerase reverse tranase (TERT) promoter mutation in glioma. [PDF]

Quant Imaging Med Surg
Wang J, Qu D, Zhang H, Zhang H.
europepmc   +1 more source

Symptom management in isocitrate dehydrogenase mutant glioma. [PDF]

Neurooncol Pract
Walbert T, Avila EK, Boele FW, Hertler C, Lu-Emerson C, van der Meer PB, Peters KB, Rooney AG, Templer JW, Koekkoek JAF.   +9 more
europepmc   +1 more source

Venous thromboembolism incidence shortens survival in isocitrate dehydrogenase wild-type glioblastoma. [PDF]

Neurooncol Adv
Sloan AR, Gordillo AJ, Kennemer A, Khorana AA, Horbinski C, Kaelber DC, Cameron SJ, Lathia JD.   +7 more
europepmc   +1 more source

Prognostic Biomarkers in Isocitrate Dehydrogenase Wild-Type Glioblastoma: A Focus on B7-H3. [PDF]

Brain Sci
Yüceer RO, Kaya S, Balcı SN, Eğilmez HR, Yılmaz M, Erdıs E.   +5 more
europepmc   +1 more source